A study published in PNAS found that trust and knowledge about vaccination are stronger predictors of vaccination than Covid-specific factors. Background beliefs and behavior regarding vaccination in general were more than twice as predictive of the change in vaccination as beliefs about the pandemic itself.
Austrian researchers developed a detailed epidemiological model to study the spread of coronavirus in nursing homes. The agent-based simulation tool helps balance safety and quality of life, considering vaccination rates and testing accuracy. With a high vaccination rate, major outbreaks are no longer expected.
New research reveals that COVID-19 vaccinated kidney transplant recipients have impaired antibody responses against emerging SARS-CoV-2 variants, including B.1.351 and B.1.617.2. The study found that these patients require additional vaccinations to maintain high levels of neutralizing antibodies.
Researchers developed a fair-diverse allocation optimization framework to optimize the distribution of COVID-19 vaccines, treatments, and testing supplies. The model aims to get limited resources to the most vulnerable subgroups while ensuring fairness and diversity, independent of demographic background.
A new study reveals the sophisticated mechanism by which adenoviruses infect human cells and transfer foreign DNA into their nucleus. Protein V plays a crucial role in increasing the virus particle's stability and preventing premature DNA release, which triggers an anti-viral alarm system.
A COVID-19 antibody survey in Sierra Leone found significant underreporting of cases and low vaccination rates, posing a risk to populations with limited immunity. The study's findings call for rapid vaccine deployments and support for intellectual property waivers to address the pandemic's progression.
Despite receiving three vaccinations, kidney transplant patients have inadequate cellular and humoral protection against SARS-CoV-2, with around 90% showing little to no protection. Researchers are now investigating the efficacy and safety of a human antibody cocktail in these patients.
Researchers create plan for proactively developing drug cocktails against virus families, aiming to provide effective treatments in weeks, not months. The approach prioritizes combination therapy to reduce disease spread and limit viral adaptation.
Researchers evaluated the quality of supporting evidence for FDA emergency use authorizations of COVID-19-related diagnostic tests, medical devices, and treatments. The study found that some authorizations lacked adequate evidence to support their approval.
A study found that Covid-19 vaccine protection wanes after three months, increasing the risk of hospitalization and death from severe disease. Booster programs are recommended to maintain maximum protection.
A Phase II trial will investigate a prime-boost regimen using two different COVID-19 vaccines, with the goal of expanding access to vaccines in Africa. The study aims to demonstrate the safety and efficacy of a mixed schedule of COVID-19 vaccines.
A new study found that multi-level interventions promoting staff training and early HPV vaccination starting at age 11 can sustain on-time vaccinations over several years. These findings suggest that targeted public health investments can improve vaccination rates, saving lives from HPV-related cancers.
A study by Iowa State University found that vaccine scarcity reduces perceived vaccination priority and increases vaccine hesitancy. Participants with higher levels of compassion were less likely to book an appointment when vaccines were described as scarce.
A new study suggests that breakthrough infections generate 'super immunity' to COVID-19, providing a robust immune response against the delta variant and potentially other variants. The study found that antibodies generated from breakthrough cases were 1,000% more effective than those from vaccinated individuals.
A study of nearly 5 million Danish residents finds mRNA vaccines associated with a low risk of myocarditis or myopericarditis after COVID-19 vaccination, particularly for Moderna and Pfizer-BioNTech. Absolute numbers are low, even in younger age groups.
Researchers have discovered a fundamental role of the TBK1 enzyme in deciding B cell fate, crucial for developing effective vaccines for diseases like COVID-19 and malaria. The study reveals that TBK1 is necessary for germinal center formation and high-quality antibody production.
Research from Queen Mary University of London and Cardiff University found that certain MS treatments can reduce Covid-19 vaccine effectiveness in people with MS. The largest peer-reviewed study on the topic provides high-quality evidence to inform clinicians' guidance on treatment options.
A novel vaccine, TOH-Vac1, replicates inside the body's cells and generates a powerful immune response in mice and monkeys. The vaccine is based on a strain of vaccinia virus used to vaccinate against smallpox and can be programmed to protect against multiple variants.
A new poll of people over 50 finds most are finding joy and staying resilient amid the pandemic, but a sizable minority feel significant stress, particularly about COVID-19 risk. The poll highlights the importance of focusing on those in poor health and finding safe ways to enjoy favorite activities.
A study published in CMAJ found that hospital health care workers in Quebec had high seroprevalence of SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic. The highest rates were reported in hospitals with outbreaks, particularly those from older facilities.
Researchers at La Jolla Institute for Immunology identified Th1* cells as a key marker in the body's immune signature following BCG vaccination. The study found that these cells respond well to the vaccine and can help fight the Mycobacterium tuberculosis bacterium that causes TB.
A new study found that Omicron's immune-evading capabilities are significant, but some vaccinated and previously infected individuals have 'stronger' protection. However, the protection from Omicron may be compromised over time.
The coating protects bacteria during the freeze-drying and manufacturing process, allowing them to be used therapeutically. The researchers tested the coating on a strain of E. coli and another species that aids in digestion of plant starches.
Researchers found that transient depletion of regulatory T cells induces dendritic cell maturation and generates adaptive immune responses against emerging SARS-CoV-2 antigens. This discovery may improve current vaccine strategies by eliminating the need for adjuvants.
A recent study published in JAMA Network Open found that implementing lottery programs as an incentive for COVID-19 vaccination led to substantial increases in vaccine uptake. The study analyzed data from over 40 states and showed a strong correlation between the implementation of these programs and subsequent vaccine adoption.
A survey of 9 European countries and the US found significant differences in vaccine skepticism, with Russia having the lowest percentage at 62% and the UK the highest at 93.9%. Factors such as media use, mental health, and government communication played a role in shaping attitudes towards vaccination.
Researchers report that combining infection and vaccination produces high-quality antibodies effective against COVID-19 variants. The study found that prior-infected individuals who received a vaccine had potent antibodies against new variants, contrary to previous findings suggesting reduced potency.
A study found that obesity is associated with severe COVID-19 outcomes, including hospital admission or death. Additionally, accelerated immunosenescence may be a key mechanism explaining the relationship between obesity and T2DM in severe COVID-19. Vaccination effectiveness may also be impacted by metabolic disorders.
A new study is investigating the immune response to COVID-19 vaccines and vaccine hesitancy among three First Nations communities in Canada. The study aims to explore the effectiveness and safety of COVID-19 vaccines in these communities, with a focus on addressing historical and colonial health disparities.
A study by Boston Children's Hospital found that COVID-19 vaccination-related myocarditis is usually mild and has a fast clinical recovery rate in adolescents and young adults. However, long-term monitoring of heart health is recommended due to potential cardiac complications.
A survey of 1,100 parents found that COVID-19 vaccine hesitancy differed by factors such as racial and ethnic background, education level, and previous experience with COVID-19. The study highlights the need for tailored vaccination strategies to address these disparities.
A new rapid test developed by Duke University researchers can measure patient immunity against multiple COVID-19 variants like Omicron and Delta. The CoVariant-SCAN test uses a polymer brush coating to detect neutralizing antibodies, allowing for quick and accurate assessment of antibody effectiveness.
A new opinion piece argues that hospitals have an ethical duty to care for unvaccinated severe COVID-19 patients, even if it means delaying non-emergency procedures for vaccinated individuals. The author suggests a contingency care standard prioritizing emergency life-support regardless of vaccination status.
A new particulate saponin/TLR agonist vaccine adjuvant has been shown to alter lymph flow and modulate adaptive immunity. This study demonstrates the potential of this ingredient as a more effective vaccine booster.
Researchers have identified pigtailed macaques as a suitable animal model for studying two emerging tick-borne hemorrhagic viruses, Kyasanur Forest disease and Alkhurma hemorrhagic disease. The study found that infected macaques exhibited symptoms similar to those in humans, including loss of appetite, dehydration, and hemorrhaging.
A study found that nearly two-thirds of US states failed to follow CDC guidelines for prioritizing cancer patients for COVID-19 vaccinations. The lack of clarity in defining qualifying cancer diagnoses led to unequal vaccination priority, leaving vulnerable patients at risk.
A study by Imperial College London found that the first SARS-CoV-2 spike protein encountered through vaccination or infection influences subsequent immune responses to current and future variants. This 'immune imprinting' affects the rate of decay of protection and impacts antibody levels over time.
A recent study published in PLOS Pathogens found that the COVID-19 Delta variant may have a reduced ability to be neutralized by vaccines. The researchers analyzed serum samples from vaccinated individuals and found that the Delta variant was more effective at evading vaccine-induced immunity than other variants, such as Beta and Alpha.
Researchers at University at Buffalo successfully freeze-dried a liposome-based liquid vaccine formula, offering a thermostable solution for future COVID-19 vaccines. The freeze-dried product showed stability at elevated temperatures and induced effective antibody responses in mice.
A Canadian study found that delaying the second dose of an mRNA COVID-19 vaccine produces a stronger immune response, which could inform international vaccination strategies. This longer dose interval strategy enables early access to first doses and ensures better protection with the two-dose series.
A study published in Frontiers in Medicine found that patients who survive severe Covid-19 have a significantly greater chance of dying over the next year. The risk is highest for those under 65, with a 233% increased chance of dying compared to uninfected individuals.
The study found that the Moderna vaccine offered a lower risk of documented infection (21% reduced), symptomatic COVID-19 (44% reduced), hospitalization (55% reduced), ICU admission (10% reduced), and death (2% reduced) compared to the Pfizer vaccine. The results suggest that either vaccine is effective, but Moderna may be slightly mor...
A new programme is seeking to understand the rare condition of blood clotting with low platelets in COVID-19 infection and vaccination. The vast majority of people experience mild reactions, but some develop severe side effects, including blood clots and low platelet levels.
A large-scale study of over 1.2 million people found breakthrough COVID-19 infections are rare but more frequent and severe in those with weakened immune systems. The study supports the introduction of a third vaccine dose for immunocompromised individuals to increase protection.
The study found that indoor bars, private parties, and nightclubs were high-risk places for transmitting the Delta variant, with men being more susceptible. Previous infection conferred a 95% protective effect, while two doses of mRNA vaccines provided 67% protection against symptomatic infection.
A new study published in The Lancet Respiratory Medicine found that children with poorly controlled asthma are three to six times more likely to be hospitalized with Covid-19. Experts advise vaccinating these children to reduce the risk of infection and spread in schools and households.
A nationwide study found decreased cervical cancer incidence and death rates among women and girls aged 15-24 after HPV vaccine introduction. The decline was more pronounced in the younger age group compared to those aged 25-29 and 30-39, suggesting a potential association with vaccination.
A Kaiser Permanente study found the Moderna COVID-19 vaccine to be 87% effective in preventing COVID-19 infection and 96% effective in preventing hospitalization. The vaccine's effectiveness persisted even among those with underlying conditions, providing reassurance about its durability.
Researchers have discovered that ulvan extracted from marine algae can prevent the infection of cells with the Corona virus. The study suggests that this cheap and accessible natural material may help solve the global spread of the pandemic in developing countries without access to vaccines.
A recent study estimates that COVID-19 vaccination prevented almost 470,000 deaths among people aged 60 years and older across Europe. The authors found that early implementation of vaccination was associated with the largest reduction in expected deaths.
A study using GDPR-compliant mobile phone data found significant decreases in household mixing during the first two lockdowns, but increases during the third, coinciding with the vaccine rollout.
Antibodies that mimic the SARS-CoV-2 virus may explain lingering symptoms of long-haul COVID-19 and rare vaccine side effects like allergic reactions and blood-clotting. This theory, based on classic immunological concepts, suggests a cascade of immune responses that can lead to adverse effects.
A study found that covid infection risk gradually increases after a second vaccine dose, with protection waning over time. The research suggests that a third (booster) dose might be warranted to prevent breakthrough infections.
A survey of 1,300 healthcare professionals found that emotional distress was associated with the pandemic's severity and lack of vaccination options. The study suggests that healthcare workers may have been at increased risk of mental health issues during this time.
A real-world study of BBV152 found that two doses resulted in 50% effectiveness against symptomatic COVID-19 in hospital workers. The study's findings support the importance of a second dose for maximum protection, but highlight limitations in estimating vaccine effectiveness against severe outcomes.
A study found that individuals under 65 had higher antibody levels than those over 65, with women outperforming men. However, by six months post-vaccination, antibody levels dropped significantly for everyone in the study group.
A mathematical model suggests that SARS-CoV-2 Delta-like variants, which combine enhanced transmissibility and partial immune escape, will cause more severe pandemics than variants with either trait alone. Vaccination is predicted to be highly beneficial in these cases, preventing more infections and breakthroughs.
People taking immunosuppressants, especially TNF inhibitors, have a weaker antibody response to COVID-19 vaccines. A third dose can drive antibody levels back up, but the duration is unknown.
A recent CDC analysis found that vaccination rates among US hospital personnel stalled after initial uptake, with 30% remaining unvaccinated as of September 2021. The analysis, which included data from over 3.3 million healthcare workers, revealed that vaccine mandates and educational efforts could help improve coverage.
A recent study found that low-, middle-, and high-income countries hosting COVID-19 vaccine trials received proportionately more doses of vaccines. High-income countries were able to fully vaccinate their populations due to the higher dose allocation, raising concerns about unequal access to life-saving vaccines.